This opportunity funds ancillary research studies leveraging RECOVER data and biospecimens, including those from clinical trials, to study the pathobiological mechanisms of Long COVID. Projects may last up to 12 months, with budgets up to $800,000 annually. Multidisciplinary approaches are encouraged, and strong justification is needed for 2-year proposals. Applicants must meet criteria in ROA OTA 21-015L and adhere to budgetary restrictions.
Eligible applicants include investigators affiliated with academic institutions, government agencies, non-profit organizations, and other eligible institutions. Prior RECOVER funding recipients for pathobiology studies may also apply. Multidisciplinary study proposals are encouraged.
